SCHEMBL2531971

SCHEMBL2531971

CC(C)CCC(=O)OCCO

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.43
MGLL Q99685 1/20 0.41
ADRA2A P08913 1/20 0.40
ADRA1A P35348 1/20 0.40
MAPT P10636 1/20 0.39
BLM P54132 1/20 0.39
CYP19A1 P11511 1/20 0.39
DGKA P23743 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
ACHE P22303 2/20 0.36
TSHR P16473 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPK1 P28482 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
CA12 O43570 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2530843 0.88 CA1 (0.40) CA1MGLLADRA2AADRA1AMAPT
SCHEMBL2531968 0.88 MGLL (0.46) CA1MGLLADRA2AADRA1AMAPT
SCHEMBL4292777 0.86 CYP19A1 (0.49) CA1ADRA2AADRA1AMAPTBLM
SCHEMBL2528042 0.86 CA1 (0.39) CA1ADRA2AADRA1AMAPTBLM
SCHEMBL433535 0.86 DGKA (0.47) MGLLMAPTDGKATDP1TSHR
SCHEMBL821822 0.85 ADRA2A (0.43) MGLLADRA2AADRA1AMAPTBLM
SCHEMBL14308492 0.84 CA1 (0.44) CA1ADRA2AADRA1AMAPTBLM
SCHEMBL25886908 0.84 CA1 (0.44) CA1ADRA2AADRA1AMAPTBLM
SCHEMBL2533187 0.84 NAAA (0.41) CA1DGKAACHECNR1CNR2
SCHEMBL2529017 0.84 NAAA (0.41) CA1DGKAACHECNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461135-B2 Boron-containing small molecules as anti-inflammatory agents ANACOR PHARMACEUTICALS, INC. (US) 2013-06-11 US claimed
US-8039450-B2 Boron-containing small molecules as anti-inflammatory agents ANACOR PHARMACEUTICALS, INC. (US) 2011-10-18 US claimed
CN-103060030-B Diesel additive composition containing alkyl ethylene glycol acetamide and application thereof CHINA PETROLEUM & CHEMICAL 2015-04-29 CN disclosed
CN-103060029-B Diesel additive composition containing alkyl ethylene glycol acetic acid polyol ester and application thereof CHINA PETROLEUM & CHEMICAL 2015-03-18 CN disclosed
CN-102453561-B Diesel oil additive and application thereof to low-sulfur diesel oil CHINA PETROLEUM & CHEMICAL 2014-05-28 CN disclosed
CN-102453562-B Organic amide low-sulfur diesel oil lubrication additive and application thereof CHINA PETROLEUM & CHEMICAL 2014-04-30 CN disclosed
US-8637557-B2 Aminothiazole derivative TAISHO PHARMACEUTICAL CO., LTD (JP) 2014-01-28 US disclosed
CN-103060029-A Diesel additive composition containing alkyl ethylene glycol acetic acid polyol ester and application thereof CHINA PETROLEUM & CHEMICAL 2013-04-24 CN disclosed
CN-103060030-A Diesel additive composition containing alkyl ethylene glycol acetamide and application thereof CHINA PETROLEUM & CHEMICAL 2013-04-24 CN disclosed
US-20120220767-A1 AMINOTHIAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-08-30 US disclosed
US-5830936-A THERMAL STABILIZERS FOR POLYOLEFINS AND ENGINEERING PLASTICS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120220767-A1 AMINOTHIAZOLE DERIVATIVE AKT3, AKT2, JAK1 CA1 4541/4885MGLL 462/4885ADRA2A 1457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.